Vimarsana
Biggest News Aggregation in the World

Page 42 - Nasdaq Regn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Regn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Regn Today - Breaking & Trending Today

Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $985.00 - Vimarsana News

Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $985.00

Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its target price hoisted by BMO Capital Markets from $960.00 to $985.00 in a research report report published on Monday morning, Marketbeat.com reports. They currently have an outperform rating on the biopharmaceutical company’s stock. A number of other research analysts have also commented on REGN. StockNews.com initiated coverage […]

Source: wkrb13.com
Regeneron Pharmaceuticals (NASDAQ:REGN) PT Raised to $925.00 at Barclays - Vimarsana News

Regeneron Pharmaceuticals (NASDAQ:REGN) PT Raised to $925.00 at Barclays

Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price objective increased by Barclays from $900.00 to $925.00 in a research report sent to investors on Monday morning, Marketbeat reports. Barclays currently has an overweight rating on the biopharmaceutical company’s stock. Other research analysts have also recently issued research reports about the company. Oppenheimer raised their […]

Regeneron Pharmaceuticals (NASDAQ:REGN) PT Raised to $925.00 at Barclays - Vimarsana News

Regeneron Pharmaceuticals (NASDAQ:REGN) PT Raised to $925.00 at Barclays

Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target lifted by investment analysts at Barclays from $900.00 to $925.00 in a report issued on Monday, Marketbeat Ratings reports. The firm currently has an “overweight” rating on the biopharmaceutical company’s stock. Barclays‘s target price would suggest a potential upside of 10.04% from the stock’s […]

Source: wkrb13.com
Insider Selling: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) EVP Sells 11,665 Shares of Stock - Vimarsana News

Insider Selling: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) EVP Sells 11,665 Shares of Stock

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) EVP Neil Stahl sold 11,665 shares of Regeneron Pharmaceuticals stock in a transaction dated Tuesday, August 22nd. The stock was sold at an average price of $840.98, for a total value of $9,810,031.70. Following the transaction, the executive vice president now owns 53,100 shares of the company’s […]

Source: wkrb13.com
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stake Raised by ExodusPoint Capital Management LP - Vimarsana News

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stake Raised by ExodusPoint Capital Management LP

ExodusPoint Capital Management LP increased its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 67.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,833 shares of the biopharmaceutical company’s stock after acquiring an additional 12,777 shares during […]